The discovery of FGF14 GAA•TTC repeat expansions in a subset of pathologically confirmed MSA patients in our study introduces significant challenges for accurate and complete clinical diagnosis of these two conditions (MSA and SCA27B), when they co-exist. The gene discussed is FGF14; the disease is multiple system atrophy.